SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : MCAR -- Ignore unavailable to you. Want to Upgrade?


To: Ditchdigger who wrote (411)4/20/1999 2:41:00 PM
From: richroni  Read Replies (1) | Respond to of 467
 
I have the misfortune of owning a stock (ANCR) that did some financing using a Reg D placement. It was also a "floorless convertible" The stock was driven down from about $7 to $1 and the number of shares increased from 12 to 24 million during the conversion. It was really scary watching the stock get beaten back on every attempt by the stock to gain. Luckily the stock eventually rebounded to a high of $9 (currently $5)based mostly on the company's potential in an up and coming technology. If I was a current shareholder in MCAR I would sell and wait to see how the company survives the "death spiral" conversion. I do not know if MCAR has any protection against this type of activity or if, in fact, their Reg D financing is "floorless" But, I would be greatly concerned.



To: Ditchdigger who wrote (411)4/23/1999 12:16:00 AM
From: Monique C. Cushman  Read Replies (1) | Respond to of 467
 
Many thanks Ditchdigger for the links.
I'll most likely stay on the side line for now, having taken a decent profit when I sold all my shares recently.
There might be an upward movement toward the end of next week, if 1st Q results come out, and early May as MedCare will be at a conference.
I talked to Bill Mann today. He told me about the conference but he could not give me a date for the quarter results release, only saying that they will be out by the end of April.

Good luck in your investments.

Monique